Results 11 to 20 of about 24,887 (213)
Therapeutic applications of octreotide in pediatric patients [PDF]
The Saudi Journal of Gastroenterology, 2012 Background/Aim: We report our experience with the use of octreotide as primary or adjunctive therapy in children with various gastrointestinal disorders.
Abdulrahman Al-Hussaini, Decker Butzner
doaj +2 more sources
Octreotide for acromegaly [PDF]
Expert Review of Endocrinology & Metabolism, 2007 Octreotide has dramatically changed the results of medical treatment of acromegaly. It is the reference drug for the pharmacological treatment of acromegaly, owing to its impressive efficacy in suppressing growth hormome secretion, and excellent compliance.
R. Cozzi, R. Attanasio
openaire +3 more sources
Octreotide and chylothorax [PDF]
Current Opinion in Pulmonary Medicine, 2006 This article reviews the current literature concerning the role of somatostatin and its synthetic analogue, octreotide, in the treatment of chylothorax.Management of chylothorax includes evacuation of the pleural cavity through a chest tube to alleviate dyspnoea, and dietary fat restriction aimed at reducing lymph flow.
Kalomenidis, Ioannis
openaire +4 more sources
Octreotide-induced thrombocytopenia: a case report [PDF]
Journal of Medical Case Reports, 2011 Introduction Thrombocytopenia is an extremely rare complication of octreotide therapy and can be life threatening in the setting of esophageal variceal bleeding.
Rizvi Nahid, Rashidi Armin
doaj +2 more sources
Octreotide in the therapy of recurrent medulloblastomas [PDF]
Archive of Oncology, 2006 BACKGROUND: Recurrence of medulloblastoma appears after 30% to 40% of the surgeries. Different from primary medulloblastoma, in which five-year survival rate is 50%, the survival time of relapses much shorter and only 20% of the patients manage to ...
Stefanović Ivan +3 more
doaj +3 more sources
Octreotide treatment of patients with hepatocellular carcinoma - a retrospective single centre controlled study [PDF]
Journal of Experimental & Clinical Cancer Research, 2009 Background Studies of treatment with octreotide of patients with hepatocellular carcinoma (HCC) gave conflicting results. We analyzed retrospectively the survival of our patients treated with octreotide monotherapy and compared it to stage-matched ...
Müller Christian +3 more
doaj +2 more sources
New England Journal of Medicine, 1996 A peptide inhibiting the release of growth hormone was originally detected accidentally during studies of the distribution of growth hormone–releasing factor in the hypothalamus of rats. This peptide, called somatostatin, proved to be a cyclic peptide consisting of 14 amino acids.
Lamberts, Steven W.J. +3 more
openaire +3 more sources
Additional file 1 of Automated GMP compliant production of [18F]AlF-NOTA-octreotide [PDF]
, 2020 Additional file 1: Figure S1. Representative chromatogram (220 nm) of the formulation solution (blank). Figure S2. Radiochromatogram of [18F]AlF-NOTA-octreotide. A) Analytical chromatogram of [18F]AlF-NOTA-octreotide at the end of synthesis.
Kim Serdons (2335297) +7 more
core +1 more source
Digestion, 1999 complications following pancreatic surgery). Somatostatin analogues including octreotide have been shown to reduce pressure in the splanchnic circulation, an effect that was exploited in the management of variceal and nonvariceal hemorrhages. Despite a widespread therapeutic application, octreotide seems to be a safe drug free of major side effects ...
M W, Büchler, C, Beglinger
openaire +2 more sources
LDL physical properties, lipoprotein and Lp(a) levels in acromegalic patients. Effects of octreotide therapy [PDF]
, 2000 High vascular morbidity and mortality is associated with acromegaly. The aim of the present study was to assess the effects of octreotide therapy on several known cardiovascular risk factors and to correlate them with octreotide-induced hormonal changes.
G. Sartore +7 more
core +1 more source